ERBB2 and breast neoplasm: The TNBC cell line MDA-MB-231 displayed the lowest expression level of drug transporters, indicating a subtype-specific and distinctive functional role of these proteins in mediating stemness and aggressiveness in HER2+ and luminal A breast tumor subtypes.